These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 6800910

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY, Haus E, Lakatua DJ, Bogdan C, Petrescu E, Sackett-Lundeen L, Stelea S, Stelea P.
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [Abstract] [Full Text] [Related]

  • 5. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR, Biggs PI, Shetty KJ, Wragg KG.
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
    Sönksen PH, Lowy C, Perkins JR, Lim HS.
    Diabetes Care; 1984 Sep; 7 Suppl 1():59-66. PubMed ID: 6376030
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.
    Hother-Nielsen O, Schmitz O, Andersen PH, Pedersen O, Beck-Nielsen H.
    Diabetes Res; 1988 Jun; 8(2):63-70. PubMed ID: 3147830
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients.
    Taniguchi A, Fukushima M, Sakai M, Tokuyama K, Nagata I, Fukunaga A, Kishimoto H, Doi K, Yamashita Y, Matsuura T, Kitatani N, Okumura T, Nagasaka S, Nakaishi S, Nakai Y.
    Metabolism; 2001 Apr; 50(4):477-80. PubMed ID: 11288046
    [Abstract] [Full Text] [Related]

  • 15. Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial.
    Katoh S, Hata S, Matsushima M, Ikemoto S, Inoue Y, Yokoyama J, Tajima N.
    Metabolism; 2001 Apr; 50(4):414-7. PubMed ID: 11288035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glibenclamide and gliquidone in the treatment of non-insulin-dependent diabetes mellitus.
    Nikkilä K, Groop L.
    Acta Med Scand; 1982 Apr; 211(1-2):13-7. PubMed ID: 6803519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA, Lang DA, Phillips MR, Turner RC.
    Diabetes Care; 1981 Apr; 4(2):293-5. PubMed ID: 6783374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.